Ketamine Infusion Therapy for Addiction & Substance Abuse Disorder in Los Altos CA

The answer is yes, ketamine infusions are showing remarkable results in not only curbing cravings but we have also used it to help wean patients off substances like Methadone with only mild withdrawal symptoms. Although this treatment may not work for everyone, it’s been exciting to see our patients not only have success with sobriety but also with minimal withdrawal symptoms!

For addiction treatments, we use the same series of six infusions that we use for depression, anxiety, OCD, etc. The 6 treatments over the course of two weeks have the same brain reboot effect. It’s believed the new synaptic connections made are producing the needed glutamate that helps change the brain’s ability to deal with cravings, behaviors, and motivation that may normally be a struggle. Booster infusions are often needed to help keep cravings at bay. Most patients begin a booster regimen of every 3-8 weeks with many patients scheduling boosters as needed, especially if they are suddenly struggling with cravings due to environmental stressors. It is normal to need random infusions as needed between scheduled boosters.

This is a very logical question with a pretty easy answer; ketamine administered through IV infusion under the care of our medical staff is very safe and non-habit forming due to the infrequency of infusions. In fact, most patients report no desire to drink or use any substance between boosters, even patients without a history of substance abuse! Ketamine infusions are shown to be a thrilling new tool for those struggling with addiction, enabling them the freedom to live the life they want. Should you or someone you know have any further questions regarding the safety and effectiveness of ketamine infusions please call us or schedule an appointment online. Our clinic is conveniently located at 746 Altos Oaks Drive Los Altos, CA 94024. We serve patients from Los Altos, CA, Sunnyvale CA, Palo Alto CA, Stanford CA, Atherton CA, Cupertino CA, and BEYOND.